TET2 and myeloid neoplasm: Mutation of ten-eleven translocation 2 (TET2), an epigenetic regulator in haematopoietic stem and progenitor cells (HSPCs) is often observed in myeloid malignancies and results in increased self-renewal and myeloid proliferation in patients (Cimmino et al., 2017).